Eric Naumann

Background

About Eric Naumann

I am a senior research regulatory consultant supporting Phase I-IV oncology and cardiovascular studies from study start-up to study closure. I have played a pivotal role in major projects including the transition of OhioHealth oncology research from Columbus NCORP to a National Cancer Institute (NCI) signatory institution and the implementation of the eRegulatory system Florence. I serve as the lead OhioHealth representative with all four groups within the NCI: Alliance, NRG, SWOG, and ECOG. I am also part of the team implementing CAR-T products at OhioHealth and work alongside the OhioHealth Research Institute to continuously expand opportunities available to our patients. Previously, I worked as a research assistant for clinical and pre-clinical research supporting the blood and bone marrow transplant team at The Ohio State University. I participated in multiple, successful FDA audits and supported a multitude of research studies through data collection and reporting. Additionally, I participated in pre-clinical Leukemia research focusing on the bone marrow niche and possible RNA treatments. I graduated from The Ohio State University with my master's in Translational Pharmacology with a focus on clinical pharmacology and clinical trial design in 2024. I previously graduated from The Ohio State University with a bachelor's in microbiology and pharmaceutical sciences in 2022. I gained research experience in a multitude of clinical and pre-clinical disciplines while an undergraduate student and after graduation. This was highlighted by winning the Denman Undergraduate Research Forum and multiple publications.